The company's revenue increased by 9.5% from last year to ₹107.1 crore and when compared to the March quarter, the topline grew by 5.6%.
Net profit for the period declined by 23% from last year and 41% from the previous quarter to ₹7.7 crore.
EBITDA margin for the quarter narrowed to 16.2% from 18.4% last year and 20.4% from the previous quarter.
The company in a press release said that all of its existing four hospitals are doing well and that they remain committed to becoming a 1,000-bed chain within the next 2-3 years. As
The planned hospital in Jamshedpur is likely to be commissioned by the end of financial year 2027.
Shares of GPT Healthcare are trading 11% lower on Thursday at ₹159.11, with this fall, the stock has declined below its IPO price of ₹186. This is the third straight day of losses for the stock.